Yan Cheng
10PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 05, 2026
Integrated Analysis Reveals ZNF184 as a Novel Regulator of Stemness-Associated Paclitaxel Resistance and Tumor Progression in Breast Cancer.Rong Gong, Yizhi Li, Xiaoya Wan
|Jan 27, 2026
Targeted Degradation of eEF2K by a Structure-Guided PROTAC Strategy for the Treatment of Triple-Negative Breast Cancer.Shijun Cao, Changxin Zhong, Shilong Jiang
|Sep 05, 2025
Serine/Threonine Kinase 33 as a Novel Target of Bufalin in Treatment of Triple-Negative Breast Cancer.Shilong Jiang, Junyan Liu, Hui Li
|Aug 22, 2025
Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha.Shilong Jiang, Keyi Liu, Ting Jiang
|May 20, 2025
GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62.Rong Gong, Xiaoya Wan, Shilong Jiang
|Feb 14, 2025
Identification of a Novel Substrate for eEF2K and the AURKA-SOX8 as the Related Pathway in TNBC.Xiaoya Wan, Rong Gong, Xiaobao Zhao
Pageof 2
